Lyophilized Product Market, By Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton pump inhibitor, Anesthetic, Anticoagulant, NSAIDs, and Others), By Indication (Infectious Disease, Autoimmune Diseases, Gastrointestinal Diseases, Cancer, and Others), By Packaging Type (Vial, Syringes, and Cartridge), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Feb 2022

Code : CMI4910

Pages :326

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Challenges And Opportunities

Global Lyophilized Product Market: Restraint

The major factors that are expected to hinder the global lyophilized product market growth include product recalls. For instance, in September 2021, Eli Lilly and Company is an American pharmaceutical company., voluntarily recalled lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar (Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe), to the consumer/user level. The company recalled lot D239382D to the patient level because of a product complaint reporting that the vial of Glucagon was in liquid form instead of the powder form. The firm's investigation indicates that the liquid in the Glucagon vial could be related to the manufacturing process. The use of the liquid form of this product may fail to treat severe low blood sugar due to the loss of potency

Global Lyophilized Product Market – Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) pandemic and subsequent lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. Private healthcare sector is one of the sectors which is majorly impacted by the COVID-19 pandemic. The coronavirus pandemic has also negatively impacted the development, production, and supply of medicines and the growth of the pharmaceutical businesses of various companies across the globe. The lockdown has resulted in the closure of industrial establishments, except the manufacturing of essential commodities, and disruption in the supply chain of pharmaceuticals and kits for diagnostic and therapeutic use. Thus, the COVID-19 pandemic has affected the economy in three main ways: 1) by directly affecting the production and demand; 2) disrupting distribution channels; and 3) causing financial impact on firms and financial markets. Supply chain and manufacturing activities in India, China, and the U.S. are disrupted due to global lockdown, while many countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to the transportation of drugs from one place to another